Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
about
Quetiapine monotherapy for bipolar depressionAssessment and treatment of mood disorders in the context of substance abuseGuidelines disconcordance in acute bipolar depression: data from the national Bipolar Mania Pathway Survey (BIPAS) in mainland China.Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data.Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients.The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial.Antidepressants and suicidal behavior in bipolar disorder.A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials.Clinical features of bipolar disorder comorbid with anxiety disorders differ between men and women.The clinical-familial correlates and naturalistic outcome of panic-disorder-agoraphobia with and without lifetime bipolar II comorbidity.Comparison of mania patients suitable for treatment trials versus clinical treatmentPharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care serviceManagement of obsessive-compulsive disorder comorbid with bipolar disorder.Effects of comorbid anxiety disorders on the longitudinal course of pediatric bipolar disorders.Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized, placebo-controlled studies.Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD).Commentary on the study: impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate (Prisciandaro et al.).Discontinuity in the transition from pediatric to adult health care for patients with attention-deficit/hyperactivity disorder.Clinical assessment and crisis intervention for the suicidal bipolar disorder patient.Treatment of bipolar depression: making sensible decisions.Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study.A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use.A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report.Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.The relationship of comorbidity of mental and substance use disorders with suicidal behaviors in the Nigerian Survey of Mental Health and Wellbeing.Post-traumatic stress disorder among adolescents with bipolar disorder and its relationship to suicidality.The Pivotal Role of Psycho-Education in the Long-Term Treatment of Bipolar Disorder
P2860
Q24644541-081F5752-34FC-45F1-BE76-67181953F470Q26798232-48E99022-FF12-4184-840E-0FF79E424ACEQ30808402-55D0A870-132C-4512-A422-CE5BCB38BF9EQ30878126-2CCB1CD8-85C3-4547-82CF-5153C895A3A8Q33518341-ABF37287-EC41-4894-9C45-39A3101BE799Q33573950-B20E907C-863B-4F5F-854D-D0087F7384F3Q34616633-4A96F953-5800-470B-8821-EB1D508A1A8DQ36570781-3BF7AC7E-B3BD-4203-AA95-F89EBA891092Q36624146-722A73BE-04BF-4414-9F0D-2229E094C9A9Q36653440-663E64A7-6E45-4B72-A88C-24E474F52387Q36677653-270D2CDA-7790-46F7-BD35-60A0D3E4D4AFQ36832897-4FCB7E82-AD64-42D3-839A-C8B3C721B311Q37010932-FD156CF8-4BBA-4DAE-99B6-A61CF5F03F03Q37100104-24CA848C-ED7F-47CD-B6C0-AD3D61E39CAAQ37115466-352D80C3-A803-4E06-963A-2225D3E71245Q37400532-797A7F7D-5F3C-4412-B5F9-7C24D0E4E48FQ37403251-CBD405EC-A68A-4001-B0F0-3DDA6E8CBA64Q37429709-C96E6FF9-F5E6-40E4-8BC7-E7FB385AD2D3Q37954411-F6C63042-CC15-483A-B43F-9AF7B81DF812Q38007996-CD1386B3-653F-45F4-81D8-425DDC22D5D9Q38055292-64A56AD5-A8B5-4FC3-968F-00DDA3E15693Q38097098-91196403-8720-497A-A107-5B6F2D70F2CDQ38269372-CFE4010A-E8D6-443B-9027-D078B830FD96Q46901288-C2D4FA3E-D508-4CBE-B27B-47045A238E5FQ47878230-CCDB9080-D33C-4200-81E2-8433C42D6B52Q48732780-242BD5AA-3971-4B32-9574-91474B5C2C64Q48910862-546FA938-2D3E-4B0F-89E3-E0AE01B8910AQ50605321-83261058-B235-4D84-9870-4E35C89132F6Q51899624-650FC3E8-FAEA-4286-B1BE-1C226AB62CC4Q58465444-A83CE1DB-3347-4B2D-B4BB-E1EE1BF60941
P2860
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
@ast
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
@en
type
label
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
@ast
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
@en
prefLabel
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
@ast
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
@en
P2093
P921
P1476
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
@en
P2093
Andrew A Nierenberg
Ellen Frank
Gary S Sachs
Jane Kogan
Joseph R Calabrese
Mark H Pollack
Mark S Bauer
Michael E Thase
Naomi M Simon
Roger D Weiss
P304
P356
10.1097/01.JCP.0000138772.40515.70
P407
P577
2004-10-01T00:00:00Z